Top news of the week: 10.03.2020.

#vaccine #coronavirus #biotechnology #Antibiotics #biospace #lifesciences #pharma #pharmaceuticals #Bankruptcy #COVID

Companies And Industries

On Mar 6, 2020
@kiranshaw shared
RT @BiIndia: [email protected] wanted to be a brewmaster before building the largest biotech company in India - by @pabsgill https://t.co/0OLRwwSh4m https://t.co/GW7M5LVceV
Open

Kiran Mazumdar Shaw wanted to be a brewmaster before building the largest biotech company in India

Kiran Mazumdar Shaw wanted to be a brewmaster before building the largest biotech company in India

Biocon founder Kiran Mazumdar Shaw wanted to be a brewmaster before entering pharmaceuticals. In an interview with Twitter India, Shaw said the idea for Biocon

On Mar 6, 2020
@DNABARCODE shared
'Crazy hours, short nights': The inside story of how a buzzy biotech upstart developed a potential #coronavirus #vaccine in record time @moderna_tx via @dnabarcode https://t.co/gE7L6ou79V?
Open

'Crazy hours, short nights': The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record time

'Crazy hours, short nights': The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record time

The vaccine still needs at least 12 to 18 months of testing in people to determine if it's safe and works to prevent the coronavirus.

On Mar 9, 2020
@BioWorld shared
Biopharma equities caught in vortex of oil crash and coronavirus fears https://t.co/gCgs70ioW0
Open

Biopharma equities caught in vortex of oil crash and coronavirus fears

Biopharma equities caught in vortex of oil crash and coronavirus fears

The financial markets were delivered a one-two punch March 9 – a plunge in oil prices along with fears that the coronavirus is continuing to spread unabated. As a result, the Dow Jones ...

On Mar 6, 2020
@BiotechWorld shared
Pfizer mulling over COVID-19 R&D pact with BioNTech: report https://t.co/6CwevVWhgi https://t.co/sTzLb6PGx5
Open

Pfizer mulling over COVID-19 R&D pact with BioNTech: report

Pfizer mulling over COVID-19 R&D pact with BioNTech: report

Big Pharma Pfizer is already at work on antivirals aimed at dampening down COVID-19 in the already infected, but it's now mulling over a pact with partner BioNTech to develop a vaccine.

On Mar 3, 2020
@BiotechWorld shared
Biogen's early R&D chief Ghosh leaves to take Unity CEO post https://t.co/Rj6zlPtJJM https://t.co/NolY9V9Mf2
Open

Biogen's early R&D chief Ghosh leaves to take Unity CEO post

Biogen's early R&D chief Ghosh leaves to take Unity CEO post

Biogen’s head of early R&D Anirvan Ghosh has left the company to take up the CEO position at Unity Biotechnology. The neuroscientist joins the longevity biotech after three years leading a ...

On Mar 6, 2020
@biospace shared
Melinta's #Bankruptcy Underlines Problems with the #Antibiotics Market It's not the science. The science is there. It’s the market. #biospace #lifesciences #biotechnology #pharma #pharmaceuticals https://t.co/uQPnynBRjU
Open

Melinta's Bankruptcy Underlines Problems with the Antibiotics Market

Melinta's Bankruptcy Underlines Problems with the Antibiotics Market

Deerfield Management placed Melinta’s assets up for auction, but no other companies made competing bids, leaving Deerfield in control of the company’s assets.

On Mar 6, 2020
@BioWorld shared
Industry, academia pivot: Pipeline of #COVID-19 vaccine and therapeutic candidates doubles https://t.co/GMGC6DF4NB
Open

Industry, academia pivot: Pipeline of COVID-19 vaccine and therapeutic candidates doubles

Industry, academia pivot: Pipeline of COVID-19 vaccine and therapeutic candidates doubles

A list of biopharma companies and nonprofit entities, including academia, working feverishly to find a vaccine or antiviral treatment to address the rapidly spreading coronavirus, now known ...

On Mar 3, 2020
@BioWorld shared
Global spread of coronavirus puts financial markets into a tailspin https://t.co/y7m12xjKiB
Open

Global spread of coronavirus puts financial markets into a tailspin

Global spread of coronavirus puts financial markets into a tailspin

Concerns about the escalating global spread of COVID-19 panicked the markets big time at the close of the month. With investors rushing to the sidelines, it only took five days for the Dow ...